Journal of Vascular Surgery
Volume 51, Issue 2 , Pages 345-350 , February 2010

Echolucent or predominantly echolucent femoral plaques predict early restenosis after eversion carotid endarterectomy

  • Edit Dósa, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Semmelweis University, Budapest, Hungary
    • Blood-Brain Barrier and Neuro-Oncology Program, Oregon Health and Science University, Portland, Ore
    • Corresponding Author InformationReprint requests: Edit Dósa, MD, PhD, Blood-Brain Barrier and Neuro-Oncology Program, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, (Mail code L603) Portland, OR 7239-3098
  • ,
  • Kristóf Hirschberg, MD

      Affiliations

    • Heart Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  • ,
  • Astrid Apor, MD

      Affiliations

    • Heart Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  • ,
  • Zsuzsanna Járányi, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  • ,
  • László Entz, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  • ,
  • György Acsády, MD, DSc

      Affiliations

    • Department of Cardiovascular Surgery, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  • ,
  • Kálmán Hüttl, MD, PhD

      Affiliations

    • Heart Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary

Received 31 May 2009 ,Accepted 24 August 2009.

References 

  1. Reina-Gutiérrez T, Serrano-Hernando FJ, Sánchez-Hervás L, Ponce A, Vega de Ceniga M, Martín A. Recurrent carotid artery stenosis following endarterectomy: natural history and risk factors. Eur J Vasc Endovasc Surg. 2005;29:334–341
  2. Stoney RJ, String ST. Recurrent carotid stenosis. Surgery. 1976;80:705–710
  3. Schillinger M, Minar E. Restenosis after percutaneous angioplasty: the role of vascular inflammation. Vasc Health Risk Manag. 2005;1:73–78
  4. Insull W. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med. 2009;122:S3–S14
  5. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672
  6. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772–1778
  7. Nordestgaard BG, Grønholdt ML, Sillesen H. Echolucent rupture-prone plaques. Curr Opin Lipidol. 2003;14:505–512
  8. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis. 2005;181:125–130
  9. Novo G, Maniglia D, Corrado E, Muratori I, Sutera F, Evola S, et al. Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention. Coron Artery Dis. 2007;18:627–631
  10. Sirico G, Brevetti G, Lanero S, Laurenzano E, Luciano R, Chiariello M. Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. J Vasc Surg. 2009;49:346–351
  11. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–870
  12. Redberg RF, Vogel RA, Criqui MH, Herrington DM, Lima JA, Roman MJ. 34th Bethesda Conference: Task force #3—What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?. J Am Coll Cardiol. 2003;41:1886–1898
  13. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia (Ultrasonographic assessment of intima-media thickness and plaque occurrence). Arterioscler Thromb. 1993;13:1404–1411
  14. Geroulakos G, Ramaswami G, Nicolaides A, James K, Labropoulos N, Belcaro G, et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg. 1993;80:1274–1277
  15. Joakimsen O, Bønaa KH, Stensland-Bugge E. Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology (The Tromsø Study). Stroke. 1997;28:2201–2207
  16. Sztajzel R. Ultrasonographic assessment of the morphological characteristics of the carotid plaque. Swiss Med Wkly. 2005;135:635-3
  17. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1998;29:554–562
  18. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340–346
  19. Mayor I, Momjian S, Lalive P, Sztajzel R. Carotid plaque: comparison between visual and grey-scale median analysis. Ultrasound Med Biol. 2003;29:961–966
  20. Slevin M, Wang Q, Font MA, Luque A, Juan-Babot O, Gaffney J, et al. Atherothrombosis and plaque heterology: different location or a unique disease?. Pathobiology. 2008;75:209–225
  21. Stalenhoef AF. The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg. 2009;49:260–265
  22. Liapis CD, Kakisis JD, Dimitroulis DA, Kostakis AG. The impact of the carotid plaque type on restenosis and future cardiovascular events: a 12-year prospective study. Eur J Vasc Endovasc Surg. 2002;24:239–244
  23. Kitta Y, Obata JE, Takano H, Nakamura T, Kodama Y, Fujioka D, et al. Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries. Atherosclerosis. 2008;197:177–182
  24. Grønholdt ML, Sillesen H, Wiebe BM, Laursen H, Nordestgaard BG. Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume. Eur J Vasc Endovasc Surg. 2001;21:227–234
  25. Andersson J, Sundström J, Kurland L, Gustavsson T, Hulthe J, Elmgren A, et al. The carotid artery plaque size and echogenicity are related to different cardiovascular risk factors in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Lipids. 2009;44:397–403
  26. Liapis CD, Paraskevas KI. Factors affecting recurrent carotid stenosis. Vasc Endovascular Surg. 2005;39:83–95
  27. LaMuraglia GM, Stoner MC, Brewster DC, Watkins MT, Juhola KL, Kwolek C, et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg. 2005;41:762–768
  28. Aidinian G, Weiswasser JM, Arora S, Abularrage CJ, Singh N, Sidawy AN. Carotid plaque morphologic characteristics. Perspect Vasc Surg Endovasc Ther. 2006;18:63–70
  29. Eto H, Miyata M, Kume N, Minami M, Itabe H, Orihara K, et al. Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun. 2006;341:591–598
  30. Perler BA. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg. 2007;20:252–258

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01810-2

doi: 10.1016/j.jvs.2009.08.080

Journal of Vascular Surgery
Volume 51, Issue 2 , Pages 345-350 , February 2010